» Articles » PMID: 2992653

PACPX--a Substituted Xanthine--antagonizes Both the A1 and A2 Subclasses of the P1-purinoceptor: Antagonism of the A2 Subclass is Competitive but Antagonism of the A1 Subclass is Not

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1985 May 1
PMID 2992653
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine (PACPX) was examined for its ability to antagonize adenosine acting on the A1 and A2 subclasses of the P1-purinoceptor. A1-purinoceptors were studied in the isolated, driven left atria of the guinea-pig, and A2-purinoceptors in the isolated, carbachol-contracted taenia coli of the guinea-pig. PACPX antagonized the actions of adenosine in both types of preparation and was a more potent antagonist than 8-phenyltheophylline. The antagonism at the A2-purinoceptor was competitive with a pA2 of 5.95. The antagonism at the A1-purinoceptor was not competitive, although antagonism at the A1-purinoceptor was greater than that at the A2-purinoceptor, based on a comparison of pD2 values. The manner of antagonism of PACPX on the A1-purinoceptors of the heart was different from that found for the A1-receptors in bovine brain, implying that there is a fundamental difference between these central and peripheral A1 subclasses of P1-purinoceptor.

Citing Articles

KW-3902, a selective high affinity antagonist for adenosine A1 receptors.

Nonaka H, Ichimura M, Takeda M, Kanda T, Shimada J, Suzuki F Br J Pharmacol. 1996; 117(8):1645-52.

PMID: 8732272 PMC: 1909575. DOI: 10.1111/j.1476-5381.1996.tb15335.x.


Characterization of the adenosine receptors of the rat superior cervical ganglion.

Connolly G, Stone T, Brown F Br J Pharmacol. 1993; 110(2):854-60.

PMID: 8242261 PMC: 2175924. DOI: 10.1111/j.1476-5381.1993.tb13891.x.


Apparent affinity of some 8-phenyl-substituted xanthines at adenosine receptors in guinea-pig aorta and atria.

Collis M, Jacobson K, Tomkins D Br J Pharmacol. 1987; 92(1):69-75.

PMID: 3664093 PMC: 1853619. DOI: 10.1111/j.1476-5381.1987.tb11297.x.


Pre- and postjunctional actions of purine and xanthine compounds in the guinea-pig caecum circular muscle.

Hoyle C, Vladimirova I, Burnstock G Br J Pharmacol. 1988; 95(2):653-63.

PMID: 3228679 PMC: 1854182. DOI: 10.1111/j.1476-5381.1988.tb11688.x.


1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.

Sebastiao A, Ribeiro J Br J Pharmacol. 1989; 96(1):211-9.

PMID: 2924073 PMC: 1854313. DOI: 10.1111/j.1476-5381.1989.tb11802.x.

References
1.
Bruns R . Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts. Biochem Pharmacol. 1981; 30(4):325-33. DOI: 10.1016/0006-2952(81)90062-9. View

2.
Cooper D, Londos C, Rodbell M . Adenosine receptor-mediated inhibition of rat cerebral cortical adenylate cyclase by a GTP-dependent process. Mol Pharmacol. 1980; 18(3):598-601. View

3.
Burnstock G, Meghji P . Distribution of P1- and P2-purinoceptors in the guinea-pig and frog heart. Br J Pharmacol. 1981; 73(4):879-85. PMC: 2071490. DOI: 10.1111/j.1476-5381.1981.tb08741.x. View

4.
Griffith S, Meghji P, Moody C, Burnstock G . 8-phenyltheophylline: a potent P1-purinoceptor antagonist. Eur J Pharmacol. 1981; 75(1):61-4. DOI: 10.1016/0014-2999(81)90346-0. View

5.
Paton D . Structure-activity relations for presynaptic inhibition of noradrenergic and cholinergic transmission by adenosine: evidence for action on A1 receptors. J Auton Pharmacol. 1981; 1(4):287-90. DOI: 10.1111/j.1474-8673.1981.tb00457.x. View